Evidence map›Paper›PMID 36851289›Full record

ArticleVaccines2023

Trends in Hospitalization and Mortality for Influenza and Other Respiratory Viruses during the COVID-19 Pandemic in the United States.

Adeel Nasrullah, Karthik Gangu, Ishan Garg, Anam Javed, Hina Shuja, Prabal Chourasia, Rahul Shekhar, Abu Baker Sheikh

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Preventing respiratory syncytial virus in older adults.Canadian family physician Medecin de famille canadien · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Adeel NasrullahDivision of Pulmonology and Critical Care, Allegheny Health Network, Pittsburg, PA 15212, USA.ORCID 0000-0001-7604-6978
Karthik GanguDepartment of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Ishan GargDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106, USA.
Anam JavedDepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, PA 15512, USA.
Hina ShujaDepartment of Medicine, Karachi Medical and Dental College, Karachi 74700, Pakistan.
Prabal ChourasiaDepartment of Hospital Medicine, Mary Washington Hospital, Fredericksburg, VA 22401, USA.ORCID 0000-0001-8685-0599
Rahul ShekharDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106, USA.ORCID 0000-0002-1200-6886
Abu Baker SheikhDepartment of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106, USA.ORCID 0000-0003-0503-6961
University of New Mexico · USAllegheny Health Network · USKarachi Medical and Dental College · PKMary Washington Hospital · USUniversity of Kansas Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seasonal epidemics of respiratory viruses, respiratory syncytial virus (RSV), influenza viruses, parainfluenza viruses (PIVs), and human metapneumovirus (MPV) are associated with a significant healthcare burden secondary to hundreds of thousands of hospitalizations every year in the United States (US) alone. Preventive measures implemented to reduce the spread of SARS-CoV-2 (COVID-19 infection), including facemasks, hand hygiene, stay-at-home orders, and closure of schools and local/national borders may have impacted the transmission of these respiratory viruses. In this study, we looked at the hospitalization and mortality trends for various respiratory viral infections from January 2017 to December 2020. We found a strong reduction in all viral respiratory infections, with the lowest admission rates and mortality in the last season (2020) compared to the corresponding months from the past three years (2017-2019). This study highlights the importance of public health interventions implemented during the COVID-19 pandemic, which had far-reaching public health benefits. Appropriate and timely use of these measures may help to reduce the severity of future seasonal respiratory viral outbreaks as well as their burden on already strained healthcare systems.

Indexed as

coronavirus 2019COVID-19human metapneumovirus (MPV)influenza virusesnational inpatient sample (NIS)parainfluenza viruses (PIVs)respiratory syncytial virusrespiratory viral outbreakRSV

Identifiers

PMID36851289
PMCPMC9966237
OpenAlexW4320496953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.